Skip to main content

Advertisement

SpringerLink
Log in

Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Russo A et al. (2007) Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. Expert Opin Ther Targets 11: 1571–1586

    Article  CAS  Google Scholar 

  2. Richardson PG et al. (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348: 2609–2617

    Article  CAS  Google Scholar 

  3. Richardson PG et al. (2005) Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 352: 2487–2498

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. B Vincenzi is a Medical Oncologist in the Medical Oncology Department, D Santini is Assistant Professor in Immunology and Medical Oncology, and G Tonini is Associate Professor of Medical Oncology, at University Campus Bio-Medico, Rome, Italy.,

    Daniele Santini, Bruno Vincenzi & Giuseppe Tonini

Authors
  1. Daniele Santini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruno Vincenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Tonini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniele Santini.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santini, D., Vincenzi, B. & Tonini, G. Updated follow-up of patients treated with bortezomib for relapsed multiple myeloma. Nat Rev Clin Oncol 5, 304–305 (2008). https://doi.org/10.1038/ncponc1127

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc1127

  • Springer Nature Limited

Search

Navigation